WEDNESDAY, April 17, 2024 (HealthDay News) — Zepbound, one of the wildly popular weight-loss drugs that millions of Americans now take, eased sleep apnea in obese adults in two company trials, drug maker Eli Lilly announced Wednesday. First approved to treat obesity by the U.S. Food and Drug Administration lastContinue Reading
THURSDAY, April 11, 2024 (HealthDay News) — Four-year-old Theo Scott was born with Down syndrome, and since the age of 1 he’s also had to wear a CPAP device whenever he sleeps, to help ease his sleep apnea. He’s not alone: Eight out of 10 kids with Down syndrome haveContinue Reading
WEDNESDAY, April 10, 2024 (HealthDay News) — Phillips Respironics, the company responsible for the recall of millions of defective sleep apnea machines since 2021, must overhaul its production of the machines before it can resume making them in the United States, federal officials announced Tuesday. Under a settlement reached withContinue Reading
FRIDAY, April 5, 2024 (HealthDay News) — Obese folks are less likely to benefit from a nerve-stimulation treatment for sleep apnea that’s recently been made available to them, a new study reports. The treatment is likely to be 75% less effective among obese people with BMIs of 32 to 35,Continue Reading
WEDNESDAY, March 27, 2024 (HealthDay News) — Folks who consistently work out two to three times a week are less likely to suffer from insomnia, a new study says. That sort of long-term commitment to exercise also helps people get the recommended amount of sleep each night, according to findingsContinue Reading
THURSDAY, March 14, 2024 (HealthDay News) — Do you struggle to sleep during the week and play catch up on the weekend? Do you toss and turn all night long and start the day in a fog? Are you a napper? Or are you among the lucky folks who haveContinue Reading
FRIDAY, March 8, 2024 (HealthDay News) — Ambien, Lunesta, Sonata: Millions of bleary-eyed Americans turn to this class of so-called “Z-drugs” to get restful sleep. But how do these drugs work, and do they come with risks? Experts at the U.S. Food and Drug Administration have issued an advisory toContinue Reading
MONDAY, March 4, 2024 (HealthDay News) — Sleep apnea could have detrimental effects on the brain, causing memory or thinking problems, a new study suggests. People suffering from sleep apnea are about 50% more likely to also report having memory or thinking problems, compared to those without sleep apnea, researchersContinue Reading
WEDNESDAY, Feb. 21, 2024 (HealthDay News) — A person’s diet can influence their risk of obstructive sleep apnea, a new study says. Those who eat a healthy plant-based diet rich in vegetables, fruit, whole grains and nuts are less likely to suffer sleep apnea, according to findings published Feb. 20Continue Reading
MONDAY, Feb. 12, 2024 (HealthDay News) — Sleep apnea appears to be linked to an increased risk of heart failure among cancer patients, a new study says. Obstructive sleep apnea occurs when relaxed muscles cause a blockage of the windpipe, interrupting breathing and causing a person to temporarily wake. TheContinue Reading
MONDAY, Feb. 5, 2024 (HealthDay News) — Even mild cases of COVID can trigger insomnia in most people, a new study reports. About three out of four people with mild COVID (76%) reported experiencing insomnia following their illness. Further, nearly one in four (23%) said they’d experienced severe insomnia, accordingContinue Reading
MONDAY, Jan. 29, 2024 (HealthDay News) — Following a recall of millions of its breathing machines that began in mid-2021, Philips Respironics announced Monday that it would halt sales of all such machines within the United States. The machines include continuous positive airway pressure (CPAP) devices used by people withContinue Reading
THURSDAY, Jan. 18, 2024 (HealthDay News) — Do you drive with the window open? Sip coffee behind the wheel? Blast the car radio and sing along? Fidget and fuss in the driver’s seat? These sorts of driving habits could be a sign that you’re getting poor sleep because you sufferContinue Reading
WEDNESDAY, Oct. 11, 2023 (HealthDay News) — A medication already approved for excessive daytime sleepiness may help ease attention-deficit/hyperactivity disorder (ADHD) symptoms in adults who aren’t getting relief from available treatments, according to a small pilot study. Solriamfetol is a nonstimulant drug that is approved for sleepiness caused by narcolepsyContinue Reading